ATOS - Atossa Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 110.16M
Enterprise value -29.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.97
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.99

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-9.80%
S&P500 52-week change 32.74%
52-week high 31.3600
52-week low 30.5000
50-day moving average 30.7260
200-day moving average 30.7782

Share statistics

Avg vol (3-month) 3446.47k
Avg vol (10-day) 31.2M
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8118.83M
% held by insiders 10.04%
% held by institutions 120.66%
Shares short (14 May 2023) 47.77M
Short ratio (14 May 2023) 424.86
Short % of float (14 May 2023) 46.14%
Short % of shares outstanding (14 May 2023) 46.14%
Shares short (prior month 13 Apr 2023) 48.33M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-14.80%
Return on equity (ttm)-22.91%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -30.03M
Net income avi to common (ttm)-28.45M
Diluted EPS (ttm)-0.2200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)103.87M
Total cash per share (mrq)0.82
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)37.66
Book value per share (mrq)0.89

Cash flow statement

Operating cash flow (ttm)-22.9M
Levered free cash flow (ttm)-13.24M